TNF Pharmaceuticals, Inc. (LON:0A8D)
London · Delayed Price · Currency is GBP · Price in USD 0.0972
+0.0043 (4.57%)
At close: Aug 20, 2025
TNF Pharmaceuticals Market Cap
TNF Pharmaceuticals has a market cap or net worth of 8.15 million as of August 22, 2025. Its market cap has increased by 139.10% in one year.
Market Cap
8.15M
Enterprise Value
10.11M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since April 20, 2021, TNF Pharmaceuticals's market cap has decreased from 142.21M to 8.15M, a decrease of -94.27%. That is a compound annual growth rate of -48.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 8.15M | 222.17% |
| Dec 31, 2024 | 2.53M | -75.52% |
| Dec 29, 2023 | 10.34M | -72.56% |
| Dec 30, 2022 | 37.67M | -77.64% |
| Dec 31, 2021 | 168.49M | 18.48% |
| Apr 20, 2021 | 142.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 186.83B |
| HSBC Holdings | 167.18B |
| Shell | 158.06B |
| Unilever | 116.97B |
| British American Tobacco p.l.c. | 95.93B |
| Rolls-Royce Holdings | 87.44B |
| Rio Tinto Group | 77.05B |
| RELX PLC | 65.51B |